TBPMF News and Press, Tetra Bio-Pharma Inc From 02/14/22

Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna Canada NewsWire The proposed partnership will encompass three potential strategic pillars across supply of API, commercialization of prescription products, and co-development of pharmaceutical drug cand...

Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , Dec. 21, 2021 /CNW Telbec/ - Tetra Bio-Pharma I...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

Tetra Bio-Pharma Announces Up To $13.0 Million Marketed Public Offering of Units Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , Dec. 1, 2021 /CNW/ - Tetra Bio-Pharma Inc. (" T...

QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols Canada NewsWire Tetra Bio-Pharma Confirms Meeting with the FDA to Align on the Requirements for Marketing Authorization OTTAWA, ON , Nov. 29, 2021 /...

Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™ Canada NewsWire OTTAWA, ON , Nov. 29, 2021 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FR...

Tetra Bio-Pharma Inc. Announces Termination of "At-The-Market" Offering Canada NewsWire OTTAWA, ON , Nov. 4, 2021 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug ...

Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency PR Newswire OTTAWA, ON , Oct. 21, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) ...

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™ PR Newswire OTTAWA, ON , Oct. 14, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-deri...